Nektar Therapeutics Public Float
Nektar Therapeutics (NKTR) had Public Float of $318.00 million as of 2025-06-30, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-13
- 2025-06-30: Entity Public Float $318.00M.
- 2024-06-30: Entity Public Float $226.00M.
- 2023-06-30: Entity Public Float $109.00M.
- 2022-06-30: Entity Public Float $704.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $318.00M 10-K · filed 2026-03-13 |
| 2024-06-30 | $226.00M 10-K · filed 2025-03-14 |
| 2023-06-30 | $109.00M 10-K · filed 2024-03-05 |
| 2022-06-30 | $704.00M 10-K · filed 2023-02-28 |
| 2021-06-30 | $3.10B 10-K · filed 2022-03-01 |
| 2020-06-30 | $4.10B 10-K · filed 2021-02-26 |
| 2019-06-28 | $6.18B 10-K · filed 2020-02-28 |
| 2018-06-29 | $8.37B 10-K · filed 2019-03-01 |
| 2017-06-30 | $3.03B 10-K · filed 2018-03-01 |
| 2016-06-30 | $1.94B 10-K · filed 2017-03-01 |
| 2015-06-30 | $1.65B 10-K · filed 2016-02-29 |
| 2014-06-30 | $1.63B 10-K · filed 2015-02-26 |
| 2013-06-28 | $1.33B 10-K · filed 2014-02-27 |
| 2012-06-29 | $922.72M 10-K · filed 2013-03-01 |
| 2011-06-30 | $827.79M 10-K · filed 2012-02-29 |
| 2010-06-30 | $1.13B 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |